Full-Time

Research Associate

Molecular Immunology

Posted on 7/18/2024

Orbital Therapeutics

Orbital Therapeutics

51-200 employees

Develops RNA-based medicines and therapies

Biotechnology
Healthcare

Junior, Mid

Cambridge, MA, USA

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • B.S. or M.S. in Immunology, Biology, or related field.
  • Must have 1-4 years of industry or academic based experience.
  • Extensive experience in designing and executing molecular immunology experiments.
  • Experience working with cell culture, including primary cells, required.
  • Experience with ELISA, MSD, BLI and functional cell-based assays required.
  • Experience maintaining accurate records of experimental data in electronic lab notebook (ELN) format.
  • Understanding of statistical principles as applicable to data analysis.
  • Execution focused, team-oriented, and highly motivated with strong written and oral presentation skills.
Responsibilities
  • Work both independently and as part of a team to design and conduct studies to characterize antibodies and antibody-like proteins using techniques such as ELISA, MSD, BLI, and functional cell-based assays.
  • Culture cells with sterile technique and perform transfections into immortalized and primary cell lines.
  • Assist with developing new cell-based and biochemical assays including troubleshooting and coming up with creative solutions.
  • Maintain an organized inventory and detailed record of all experiments and important reagents in the lab.
  • Clearly communicate findings as well as challenges that arise in a timely manner.
  • Help shape R&D strategy and contribute meaningfully to building out our internal efforts to advance our autoimmune and immune-oncology programs at the forefront of scientific innovation.

Orbital Therapeutics focuses on developing RNA-based medicines, specifically targeting areas like vaccines, immunomodulation, and protein replacement. The company utilizes RNA technology, advanced delivery methods, data science, and automation to create a platform for a wide range of therapeutic applications. Unlike many competitors, Orbital Therapeutics does not work with small interfering RNA, which sets it apart in the RNA medicine space. The goal is to enhance global health by harnessing RNA medicines to treat diseases in innovative ways that were not possible before. Revenue is generated through the sale of these medicines to healthcare providers who treat patients with various conditions.

Company Stage

Series A

Total Funding

$262.6M

Headquarters

San Francisco, California

Founded

2022

Growth & Insights
Headcount

6 month growth

4%

1 year growth

0%

2 year growth

13%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in RNA vaccines post-COVID-19 boosts Orbital's market potential.
  • Advancements in lipid nanoparticle delivery enhance RNA therapeutic stability and efficacy.
  • Growing personalized medicine trend aligns with Orbital's RNA-based therapy focus.

What critics are saying

  • Competition from established pharma companies may challenge Orbital's market share.
  • Regulatory scrutiny could delay clinical trials for RNA-based therapies.
  • Rapid tech advancements in RNA delivery require continuous R&D investment.

What makes Orbital Therapeutics unique

  • Orbital Therapeutics focuses on RNA-based medicines excluding small interfering RNA.
  • The company integrates RNA technology with delivery techniques, data analytics, and automation.
  • Orbital's initial focus includes vaccines, immunomodulation, and protein replacement.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE